Announcements

23 October 2023
Current Oncology | Top Cited Papers in 2021 in the Section “Genitourinary Oncology”

As Current Oncology (ISSN: 1718-7729) is of an open access format, you have free and unlimited access to the full text of all articles published in our journal. We welcome you to read our 2021 top cited papers in the Section “Genitourinary Oncology” listed below:

1. “Immunohistochemistry for Prostate Biopsy—Impact on Histological Prostate Cancer Diagnoses and Clinical Decision Making”
by Philipp Mandel, Mike Wenzel, Benedikt Hoeh, Maria N. Welte, Felix Preisser, Tahir Inam, Clarissa Wittler, Clara Humke, Jens Köllermann, Peter Wild et al.
Curr. Oncol. 2021, 28(3), 2123–2133; https://doi.org/10.3390/curroncol28030197
Available online: https://www.mdpi.com/1718-7729/28/3/197

2. “Correlation of Urine Loss after Catheter Removal and Early Continence in Men Undergoing Radical Prostatectomy”
by Benedikt Hoeh, Felix Preisser, Mike Wenzel, Clara Humke, Clarissa Wittler, Jan L. Hohenhorst, Maja Volckmann-Wilde, Jens Köllermann, Thomas Steuber, Markus Graefen et al.
Curr. Oncol. 2021, 28(6), 4738–4747; https://doi.org/10.3390/curroncol28060399
Available online: https://doi.org/10.3390/curroncol28060399

3. “The Utility of Combined Target and Systematic Prostate Biopsies in the Diagnosis of Clinically Significant Prostate Cancer Using Prostate Imaging Reporting and Data System Version 2 Based on Biparametric Magnetic Resonance Imaging”
by Daiki Kato, Kaori Ozawa, Shinichi Takeuchi, Makoto Kawase, Kota Kawase, Chie Nakai, Manabu Takai, Koji Iinuma, Keita Nakane, Hiroki Kato et al.
Curr. Oncol. 2021, 28(2), 1294–1301; https://doi.org/10.3390/curroncol28020123
Available online: https://www.mdpi.com/1718-7729/28/2/123

4. “Extreme Hypofractionation with SBRT in Localized Prostate Cancer”
by Maria Antonia Gómez-Aparicio, Jeannette Valero, Begoña Caballero, Rafael García, Ovidio Hernando-Requejo, Ángel Montero, Alfonso Gómez-Iturriaga, Thomas Zilli, Piet Ost, Fernando López-Campos, et al.
Curr. Oncol. 2021, 28(4), 2933–2949; https://doi.org/10.3390/curroncol28040257
Available online: https://www.mdpi.com/1718-7729/28/4/257

5. “Spontaneous Regression of Metastatic Renal Cell Carcinoma after SARS-CoV-2 Infection: A Report of Two Cases”
by Tomas Buchler, Lukas Fiser, Jaroslava Benesova, Hana Jirickova and Jana Votrubova
Curr. Oncol. 2021, 28(5), 3403–3407; https://doi.org/10.3390/curroncol28050294
Available online: https://www.mdpi.com/1718-7729/28/5/294

6. “Prognostic Impact of APOBEC3B Expression in Metastatic Urothelial Carcinoma and Its Association with Tumor-Infiltrating Cytotoxic T Cells”
by Hyunho Kim, Okran Kim, Myung Ah Lee, Ji Youl Lee, Sung-Hoo Hong, U-Syn Ha, Kwangil Yim and In-Ho Kim
Curr. Oncol. 2021, 28(3), 1652–1662; https://doi.org/10.3390/curroncol28030154
Available online: https://www.mdpi.com/1718-7729/28/3/154

7. “Response to Combination of Pembrolizumab and Axitinib in Hereditary Leyomiomatosis and Renal Cell Cancer (HLRCC)”
by Ibon Gurruchaga Sotés, Ana Nuño Alves, Sandra Vicente Arregui and Carmen Santander Lobera
Curr. Oncol. 2021, 28(4), 2346–2350; https://doi.org/10.3390/curroncol28040216
Available online: https://www.mdpi.com/1718-7729/28/4/216

8. “Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer”
by Tim Wollenweber, Lucia Zisser, Elisabeth Kretschmer-Chott, Michael Weber, Bernhard Grubmüller, Gero Kramer, Shahrokh F. Shariat, Markus Mitterhauser, Stefan Schmitl, Chrysoula Vraka et al.
Curr. Oncol. 2021, 28(5), 3692–3704; https://doi.org/10.3390/curroncol28050315
Available online: https://www.mdpi.com/1718-7729/28/5/315

9. “Prostate Cancer Metastasis to the Pituitary Gland Manifesting as Corticosteroid Withdrawal, and the Impact of the Switch from Prednisone to Dexamethasone on Survival Time”
by Okeroghene Ataikiru, Mahmoud Abdelsalam, Mrudula Avileli and Trina Hynes
Curr. Oncol. 2021, 28(6), 4291–4297; https://doi.org/10.3390/curroncol28060365
Available online: https://www.mdpi.com/1718-7729/28/6/365

10. “Cost–Utility Analysis of Radiation Treatment Modalities for Intermediate-Risk Prostate Cancer”
by Najlaa Alyamani, Jiheon Song, Sasha van Katwyk, Kednapa Thavorn, Julie Renaud, Alain Haddad, Miller MacPherson and Marc Gaudet
Curr. Oncol. 2021, 28(4), 2385–2398; https://doi.org/10.3390/curroncol28040219
Available online: https://www.mdpi.com/1718-7729/28/4/219

More News...
Back to TopTop